R

RUBYnanomed

9 employees

Ruby Nanomed develops a microfluidic-based liquid biopsy device for cancer progression.

Basic info

Industry

wellness and fitness services

Sectors

microfluidic devices
cancer monitoring
Health Care
medical devices
circulating tumour cells
in-vitro diagnosis
companion diagnostics
liquid biopsy
oncology
healthcare

Date founded

2018

Funding rounds raised

Total raised

$119K

from 1 investors over 1 rounds

R

RUBYnanomed raised $119K on March 5, 2021

Investors: Portugal Ventures

FAQ